Updated: March 26, 2026
Why Is Amjevita So Hard to Find? [Explained for 2026]
Author
Peter Daggett
![Why Is Amjevita So Hard to Find? [Explained for 2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F2b02199779d58a80b34beab7750d1fab9a9406ef-1024x1024.png%3Frect%3D0%2C171%2C1024%2C683%26w%3D600%26h%3D400%26auto%3Dformat&w=1200&q=75)
Summarize with AI
Struggling to find Amjevita at your pharmacy? Learn why this Humira biosimilar can be hard to find in 2026 and what you can do to get your prescription filled.
Why Is Amjevita So Hard to Find?
You've got your prescription for Amjevita (Adalimumab-Atto) in hand, but your pharmacy says they don't have it. You call another pharmacy — same story. If this sounds familiar, you're not alone. Many patients across the country are running into the same frustrating experience when trying to fill their Amjevita prescription in 2026.
Amjevita is an important medication for people living with conditions like rheumatoid arthritis, Crohn's disease, psoriasis, and other autoimmune disorders. Going without it isn't just inconvenient — it can mean a return of painful symptoms and disease flares. Let's break down why Amjevita can be so hard to find and, more importantly, what you can do about it.
What Is Amjevita?
Amjevita is a biosimilar to Humira (Adalimumab), one of the most widely prescribed biologic medications in the world. Made by Amgen, Amjevita was the first Humira biosimilar to launch in the United States in January 2023. It contains the active ingredient Adalimumab-Atto, which works by blocking a protein called tumor necrosis factor-alpha (TNF-α) that drives inflammation in autoimmune diseases.
Amjevita is FDA-approved to treat nine conditions, including:
- Rheumatoid arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Crohn's disease (adults and children)
- Ulcerative colitis
- Plaque psoriasis
- Hidradenitis suppurativa
- Uveitis
- Juvenile idiopathic arthritis
As an interchangeable biosimilar, Amjevita can be substituted for Humira at the pharmacy without your doctor needing to write a new prescription in most states. It comes in citrate-free prefilled pens and syringes, which many patients find less painful to inject. To learn more about how Amjevita works, check out our guide to Amjevita's mechanism of action.
Why Is Amjevita Hard to Find? 4 Key Reasons
1. Specialty Pharmacy Distribution
Unlike common medications that sit on the shelf at your local pharmacy, Amjevita is a specialty biologic. Most biologics are distributed through specialty pharmacies rather than regular retail pharmacies like CVS or Walgreens. This means your neighborhood pharmacy may not routinely stock Amjevita, even if they can technically order it.
Specialty pharmacies are set up to handle the unique storage requirements of biologics — Amjevita must be kept refrigerated between 36°F and 46°F. They also provide patient support services like injection training and refill reminders. However, this specialized distribution channel can make it harder to find the medication on short notice.
2. Insurance Formulary Changes
The biosimilar market for Adalimumab is crowded and competitive. There are now more than 10 Humira biosimilars approved in the U.S., including Hadlima, Hyrimoz, Cyltezo, and Simlandi. Insurance companies and pharmacy benefit managers (PBMs) negotiate deals with different manufacturers, and formulary preferences change frequently.
Your insurer may have recently switched their preferred Adalimumab product — meaning the pharmacy they work with stocks a different biosimilar instead of Amjevita. This doesn't mean Amjevita is unavailable, but it can create confusion and delays when you try to fill your prescription.
3. The Biosimilar Transition Is Still Evolving
The shift from brand-name Humira to biosimilars like Amjevita is one of the biggest transitions in specialty pharmacy history. While Amjevita launched in 2023, many pharmacies and health systems are still adjusting their inventory and workflows. Some pharmacies may carry only one or two Adalimumab products, and Amjevita might not be one of them.
Additionally, not all healthcare providers are equally familiar with prescribing biosimilars. Some may still write prescriptions for brand-name Humira, which can add steps to the pharmacy process if you'd prefer the more affordable Amjevita option.
4. Prior Authorization Delays
Most insurance plans require prior authorization before covering Amjevita. This means your doctor's office needs to submit paperwork proving that the medication is medically necessary. If the prior authorization isn't completed or gets denied, the pharmacy can't fill your prescription — even if they have Amjevita in stock.
Prior authorization can take anywhere from a few hours to several weeks, depending on your insurance company. During that time, patients are left waiting without their medication.
What You Can Do to Find Amjevita
Use a Pharmacy Locator Tool
One of the fastest ways to find Amjevita in stock is to use Medfinder, a free tool that helps you search for pharmacies near you that currently have your medication available. Instead of calling pharmacy after pharmacy, Medfinder does the work for you. Learn more in our guide on how to find Amjevita in stock near you.
Ask About Specialty Pharmacy Options
If your regular pharmacy doesn't carry Amjevita, ask your doctor or insurance company about preferred specialty pharmacies. Many insurers have a list of approved specialty pharmacies that stock Amjevita and can ship it directly to your home with proper cold-chain packaging.
Talk to Your Doctor About Alternatives
If you can't find Amjevita or your insurance doesn't cover it, there are other options. Several Adalimumab biosimilars are available, and your doctor may be able to switch you to one that's easier to find or better covered by your plan. Read our full guide to Amjevita alternatives for more information.
Check for Savings Programs
Cost can be another barrier to access. Amgen's SupportPlus Co-Pay Program can help eligible patients with commercial insurance pay as little as $0 per month for Amjevita. If you're uninsured, the Amgen Safety Net Foundation may provide the medication for free. We cover all the options in our guide to saving money on Amjevita.
Final Thoughts
Finding Amjevita shouldn't be this hard, but the reality of specialty pharmacy distribution, insurance formulary changes, and the ongoing biosimilar transition means many patients face hurdles. The good news is that tools like Medfinder exist to help you locate your medication faster, and there are savings programs that can bring the cost down significantly.
If you're struggling to fill your Amjevita prescription, don't give up. Talk to your doctor, check with specialty pharmacies, and use every resource available to you. Your health depends on staying on your treatment, and there are paths forward.
Frequently Asked Questions
Amjevita (Adalimumab-Atto) is an FDA-approved interchangeable biosimilar to Humira (Adalimumab). It has the same mechanism of action, FDA-approved indications, dosage forms, and route of administration. Clinical studies confirmed that Amjevita has no meaningful differences in safety or effectiveness compared to Humira.
Amjevita is a specialty biologic medication that requires refrigerated storage and is typically distributed through specialty pharmacies rather than regular retail pharmacies. Your pharmacy may also stock a different Adalimumab biosimilar based on contracts with your insurance company or pharmacy benefit manager.
Yes. Amjevita is designated as an interchangeable biosimilar to Humira, meaning a pharmacist can substitute it without needing a new prescription from your doctor in most states. Talk to your doctor and pharmacist about making the switch.
Prior authorization timelines vary by insurance company but typically take 2 to 14 business days. Some insurers offer expedited reviews for urgent cases. Your doctor's office handles the paperwork, but you can follow up with your insurance company directly to check the status.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsRelated articles
32,236 have already found their meds with Medfinder.
Start your search today.

![Who Has Vyvanse in Stock Near You? Find It Today [2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F1079f61f167dcbc2ed5f1da17a0dcb0b7166357e-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)



